Senju gains Chinese rights to ophthalmic gatifloxacin
This article was originally published in Scrip
Executive Summary
Kyorin Pharmaceutical has granted fellow Japanese company Senju the exclusive right to market an ophthalmic solution of gatifloxacin in China.